Idiopathic eosinophilic myositis

Idiopathic eosinophilic myositis is an extremely rare inflammatory muscle disorder characterized by the infiltration of eosinophils (a type of white blood cell) into skeletal muscle tissue without an identifiable underlying cause. It belongs to the broader group of eosinophilic myopathies and is classified under idiopathic inflammatory myopathies. The condition primarily affects the musculoskeletal system, causing muscle pain (myalgia), muscle tenderness, proximal muscle weakness, and sometimes muscle swelling. Patients may experience difficulty with activities such as climbing stairs, rising from a seated position, or lifting objects due to progressive weakness in the limbs. Elevated levels of creatine kinase (a marker of muscle damage) and peripheral blood eosinophilia are commonly observed in laboratory findings. The disease can present in a focal form, affecting a single muscle or muscle group, or in a more diffuse pattern involving multiple muscles throughout the body. In some cases, eosinophilic infiltration may extend beyond skeletal muscle to involve other tissues, though by definition the idiopathic form lacks association with systemic eosinophilic disorders, parasitic infections, drug reactions, or other known causes of eosinophilia. Diagnosis typically requires muscle biopsy demonstrating eosinophilic infiltration, along with exclusion of secondary causes. The condition must be distinguished from eosinophilic fasciitis, eosinophilic polymyositis, and hypereosinophilic syndrome with muscle involvement. Treatment generally involves immunosuppressive therapy, with corticosteroids (such as prednisone) being the first-line treatment. Most patients respond favorably to corticosteroid therapy, with improvement in muscle strength and reduction of eosinophilic infiltration. In cases that are refractory to steroids or require steroid-sparing agents, other immunosuppressive medications such as azathioprine or methotrexate may be considered. The long-term prognosis varies, with some patients achieving sustained remission while others may experience relapses requiring ongoing treatment.

Common questions about Idiopathic eosinophilic myositis